

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.53084393 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.53084393 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.25535309 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.25535309 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.81512886 |
| 6 | exogenous drug catabolic process (GO:0042738) | 6.74542999 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.62044127 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.21331264 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.21331264 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.21331264 |
| 11 | kynurenine metabolic process (GO:0070189) | 6.00836383 |
| 12 | high-density lipoprotein particle remodeling (GO:0034375) | 5.99248173 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.81967761 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.81042257 |
| 15 | negative regulation of fibrinolysis (GO:0051918) | 5.69615728 |
| 16 | urea metabolic process (GO:0019627) | 5.68247355 |
| 17 | urea cycle (GO:0000050) | 5.68247355 |
| 18 | omega-hydroxylase P450 pathway (GO:0097267) | 5.63309371 |
| 19 | regulation of cholesterol esterification (GO:0010872) | 5.60821981 |
| 20 | glyoxylate metabolic process (GO:0046487) | 5.55283960 |
| 21 | regulation of fibrinolysis (GO:0051917) | 5.42878367 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 5.39139236 |
| 23 | protein carboxylation (GO:0018214) | 5.33286698 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.33286698 |
| 25 | epoxygenase P450 pathway (GO:0019373) | 5.30249063 |
| 26 | nitrogen cycle metabolic process (GO:0071941) | 5.21947225 |
| 27 | regulation of protein activation cascade (GO:2000257) | 5.20928499 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 5.17254271 |
| 29 | complement activation, alternative pathway (GO:0006957) | 5.16026652 |
| 30 | phospholipid efflux (GO:0033700) | 5.11771502 |
| 31 | cysteine metabolic process (GO:0006534) | 5.10419367 |
| 32 | protein-lipid complex remodeling (GO:0034368) | 5.08848373 |
| 33 | macromolecular complex remodeling (GO:0034367) | 5.08848373 |
| 34 | plasma lipoprotein particle remodeling (GO:0034369) | 5.08848373 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 5.08831955 |
| 36 | negative regulation of cholesterol transport (GO:0032375) | 5.04718378 |
| 37 | negative regulation of sterol transport (GO:0032372) | 5.04718378 |
| 38 | serine family amino acid catabolic process (GO:0009071) | 4.99230401 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.99036742 |
| 40 | bile acid metabolic process (GO:0008206) | 4.96316239 |
| 41 | aromatic amino acid family metabolic process (GO:0009072) | 4.95164520 |
| 42 | oxidative demethylation (GO:0070989) | 4.93961476 |
| 43 | S-adenosylmethionine metabolic process (GO:0046500) | 4.89809027 |
| 44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.82384746 |
| 45 | regulation of complement activation (GO:0030449) | 4.80824309 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.78101339 |
| 47 | plasma lipoprotein particle clearance (GO:0034381) | 4.63439228 |
| 48 | alpha-amino acid catabolic process (GO:1901606) | 4.57813160 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.57630607 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.57630607 |
| 51 | homocysteine metabolic process (GO:0050667) | 4.53648770 |
| 52 | lysine catabolic process (GO:0006554) | 4.47936960 |
| 53 | lysine metabolic process (GO:0006553) | 4.47936960 |
| 54 | cholesterol efflux (GO:0033344) | 4.47689036 |
| 55 | amino-acid betaine metabolic process (GO:0006577) | 4.41067634 |
| 56 | indolalkylamine metabolic process (GO:0006586) | 4.37395436 |
| 57 | drug metabolic process (GO:0017144) | 4.37047038 |
| 58 | coenzyme catabolic process (GO:0009109) | 4.36837206 |
| 59 | plasma lipoprotein particle assembly (GO:0034377) | 4.34644370 |
| 60 | cellular biogenic amine catabolic process (GO:0042402) | 4.31427153 |
| 61 | amine catabolic process (GO:0009310) | 4.31427153 |
| 62 | benzene-containing compound metabolic process (GO:0042537) | 4.28679738 |
| 63 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.26723853 |
| 64 | imidazole-containing compound metabolic process (GO:0052803) | 4.24393993 |
| 65 | glycine metabolic process (GO:0006544) | 4.20471228 |
| 66 | cellular amino acid catabolic process (GO:0009063) | 4.18662052 |
| 67 | bile acid and bile salt transport (GO:0015721) | 4.17764317 |
| 68 | cellular glucuronidation (GO:0052695) | 4.16642742 |
| 69 | drug catabolic process (GO:0042737) | 4.16563793 |
| 70 | heme transport (GO:0015886) | 4.13873245 |
| 71 | negative regulation of lipase activity (GO:0060192) | 4.13409804 |
| 72 | cellular ketone body metabolic process (GO:0046950) | 4.13394263 |
| 73 | low-density lipoprotein particle remodeling (GO:0034374) | 4.12728794 |
| 74 | glutamate metabolic process (GO:0006536) | 4.11389938 |
| 75 | arginine metabolic process (GO:0006525) | 4.06413372 |
| 76 | fibrinolysis (GO:0042730) | 4.03109475 |
| 77 | behavioral response to nicotine (GO:0035095) | 4.01641386 |
| 78 | serine family amino acid metabolic process (GO:0009069) | 4.01158351 |
| 79 | ketone body metabolic process (GO:1902224) | 4.00723319 |
| 80 | positive regulation of lipid catabolic process (GO:0050996) | 3.97441105 |
| 81 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.95200437 |
| 82 | cellular modified amino acid catabolic process (GO:0042219) | 3.91918516 |
| 83 | aldehyde catabolic process (GO:0046185) | 3.91203736 |
| 84 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.90181726 |
| 85 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.90181726 |
| 86 | cofactor catabolic process (GO:0051187) | 3.88171435 |
| 87 | protein-lipid complex assembly (GO:0065005) | 3.88115154 |
| 88 | acute-phase response (GO:0006953) | 3.87671466 |
| 89 | ethanol metabolic process (GO:0006067) | 3.85948807 |
| 90 | ethanol oxidation (GO:0006069) | 3.85928060 |
| 91 | serine family amino acid biosynthetic process (GO:0009070) | 3.85880771 |
| 92 | plasma lipoprotein particle organization (GO:0071827) | 3.84280382 |
| 93 | opsonization (GO:0008228) | 3.82491007 |
| 94 | blood coagulation, intrinsic pathway (GO:0007597) | 3.79203257 |
| 95 | alkaloid metabolic process (GO:0009820) | 3.79137288 |
| 96 | complement activation, classical pathway (GO:0006958) | 3.71760980 |
| 97 | cholesterol homeostasis (GO:0042632) | 3.71690151 |
| 98 | uronic acid metabolic process (GO:0006063) | 3.69637684 |
| 99 | glucuronate metabolic process (GO:0019585) | 3.69637684 |
| 100 | regulation of bile acid biosynthetic process (GO:0070857) | 3.68345410 |
| 101 | short-chain fatty acid metabolic process (GO:0046459) | 3.67478522 |
| 102 | NAD biosynthetic process (GO:0009435) | 3.66712126 |
| 103 | protein activation cascade (GO:0072376) | 3.66501750 |
| 104 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.66228505 |
| 105 | sterol homeostasis (GO:0055092) | 3.65267842 |
| 106 | complement activation (GO:0006956) | 3.65266875 |
| 107 | organic acid catabolic process (GO:0016054) | 3.64543571 |
| 108 | carboxylic acid catabolic process (GO:0046395) | 3.64543571 |
| 109 | phenylpropanoid metabolic process (GO:0009698) | 3.63843628 |
| 110 | protein-lipid complex subunit organization (GO:0071825) | 3.60512707 |
| 111 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.59390353 |
| 112 | flavonoid metabolic process (GO:0009812) | 3.58540656 |
| 113 | positive regulation of fatty acid transport (GO:2000193) | 3.25056542 |
| 114 | L-methionine salvage (GO:0071267) | 3.24922475 |
| 115 | L-methionine biosynthetic process (GO:0071265) | 3.24922475 |
| 116 | amino acid salvage (GO:0043102) | 3.24922475 |
| 117 | indole-containing compound metabolic process (GO:0042430) | 3.24397283 |
| 118 | cytolysis (GO:0019835) | 3.19279898 |
| 119 | sodium-independent organic anion transport (GO:0043252) | 3.18724757 |
| 120 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.16802414 |
| 121 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.14154638 |
| 122 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.08414028 |
| 123 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.08414028 |
| 124 | positive regulation of icosanoid secretion (GO:0032305) | 3.06904881 |
| 125 | vitamin biosynthetic process (GO:0009110) | 2.96107502 |
| 126 | regulation of humoral immune response (GO:0002920) | 2.95522967 |
| 127 | regulation of plasminogen activation (GO:0010755) | 2.90706745 |
| 128 | xenobiotic catabolic process (GO:0042178) | 2.90548265 |
| 129 | negative regulation of protein activation cascade (GO:2000258) | 2.86720549 |
| 130 | L-fucose catabolic process (GO:0042355) | 2.79374364 |
| 131 | fucose catabolic process (GO:0019317) | 2.79374364 |
| 132 | L-fucose metabolic process (GO:0042354) | 2.79374364 |
| 133 | regulation of glucokinase activity (GO:0033131) | 2.78959581 |
| 134 | regulation of hexokinase activity (GO:1903299) | 2.78959581 |
| 135 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.77390326 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.30675614 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.13833887 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.08315516 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.44056998 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.31851706 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.25124080 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.09201978 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.08940111 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.02441975 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.69043577 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 2.75799392 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.57961809 |
| 13 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.39346394 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.21236956 |
| 15 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.14210038 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04963782 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.03470992 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.02208629 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9459515 |
| 20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.97825807 |
| 21 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.90919243 |
| 22 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.87209344 |
| 23 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.86305991 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.83887448 |
| 25 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.83418824 |
| 26 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.66499655 |
| 27 | P300_19829295_ChIP-Seq_ESCs_Human | 1.65934280 |
| 28 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58062097 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56914237 |
| 30 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.54417415 |
| 31 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.51735193 |
| 32 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.49265857 |
| 33 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.46878841 |
| 34 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.46878841 |
| 35 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.46440942 |
| 36 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45881642 |
| 37 | FUS_26573619_Chip-Seq_HEK293_Human | 1.45301470 |
| 38 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.43878040 |
| 39 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.43878040 |
| 40 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.43552158 |
| 41 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.43552158 |
| 42 | EWS_26573619_Chip-Seq_HEK293_Human | 1.41757716 |
| 43 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.41376660 |
| 44 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.40513541 |
| 45 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.39238329 |
| 46 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.39213723 |
| 47 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.38552796 |
| 48 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.38451085 |
| 49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38252096 |
| 50 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36889508 |
| 51 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.36889508 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.36868436 |
| 53 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.36128439 |
| 54 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.34308249 |
| 55 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.33704182 |
| 56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.31565849 |
| 57 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.30290772 |
| 58 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.30185046 |
| 59 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.28912865 |
| 60 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.27570187 |
| 61 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.27279167 |
| 62 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.26737945 |
| 63 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.26091486 |
| 64 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.25764538 |
| 65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.25242815 |
| 66 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.24491933 |
| 67 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.24367814 |
| 68 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.23776838 |
| 69 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.21448962 |
| 70 | TCF4_23295773_ChIP-Seq_U87_Human | 1.21365221 |
| 71 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19702341 |
| 72 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.18259168 |
| 73 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.17914819 |
| 74 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.16503491 |
| 75 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13382271 |
| 76 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.11274618 |
| 77 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.10824916 |
| 78 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.09798526 |
| 79 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08353777 |
| 80 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.08222337 |
| 81 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.07835206 |
| 82 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.07550527 |
| 83 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.07413282 |
| 84 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.07360468 |
| 85 | ERA_21632823_ChIP-Seq_H3396_Human | 1.04202737 |
| 86 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.04161043 |
| 87 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.03701402 |
| 88 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03276871 |
| 89 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.03275398 |
| 90 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03139332 |
| 91 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.02631013 |
| 92 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.02294258 |
| 93 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01944851 |
| 94 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01815893 |
| 95 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99725643 |
| 96 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.98708098 |
| 97 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.98166832 |
| 98 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.96898334 |
| 99 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.96296392 |
| 100 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.95938698 |
| 101 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95092222 |
| 102 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.93521296 |
| 103 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88483868 |
| 104 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83163170 |
| 105 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82362269 |
| 106 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78084979 |
| 107 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76494814 |
| 108 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.76004765 |
| 109 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.75839331 |
| 110 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.75439395 |
| 111 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75311741 |
| 112 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.74965282 |
| 113 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.74068068 |
| 114 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.73359536 |
| 115 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70765706 |
| 116 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.70382682 |
| 117 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69359491 |
| 118 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68234992 |
| 119 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.66837896 |
| 120 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64738216 |
| 121 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63955331 |
| 122 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63946310 |
| 123 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63946310 |
| 124 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.63288953 |
| 125 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62572456 |
| 126 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.62259387 |
| 127 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61472409 |
| 128 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.59027221 |
| 129 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.56860378 |
| 130 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56447511 |
| 131 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.55152249 |
| 132 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.54682035 |
| 133 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.51918464 |
| 134 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51324864 |
| 135 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.49204512 |
| 136 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.48470537 |
| 137 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.48084972 |
| 138 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.47095986 |
| 139 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.46519666 |
| 140 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.46334744 |
| 141 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45823374 |
| 142 | CBP_21632823_ChIP-Seq_H3396_Human | 0.45673479 |
| 143 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.45154396 |
| 144 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44659363 |
| 145 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43502117 |
| 146 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.43068291 |
| 147 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.42123322 |
| 148 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.41691589 |
| 149 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.41407492 |
| 150 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.41390343 |
| 151 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40996248 |
| 152 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.40240940 |
| 153 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.39364924 |
| 154 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.39349720 |
| 155 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.39155475 |
| 156 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.38304216 |
| 157 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.38013065 |
| 158 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.37897687 |
| 159 | GATA2_19941826_ChIP-Seq_K562_Human | 0.37073373 |
| 160 | GATA1_19941826_ChIP-Seq_K562_Human | 0.36858864 |
| 161 | NCOR_22424771_ChIP-Seq_293T_Human | 0.36654926 |
| 162 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.36537036 |
| 163 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36405194 |
| 164 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.36137634 |
| 165 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.35384522 |
| 166 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.34827496 |
| 167 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.34169645 |
| 168 | * FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33885622 |
| 169 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.33884512 |
| 170 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.33703218 |
| 171 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.33314912 |
| 172 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.33254027 |
| 173 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.32537295 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.55325033 |
| 2 | MP0005360_urolithiasis | 7.47437852 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.43681329 |
| 4 | MP0005365_abnormal_bile_salt | 6.33584863 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.15531003 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.09901171 |
| 7 | MP0003252_abnormal_bile_duct | 3.81798876 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.57773596 |
| 9 | MP0009840_abnormal_foam_cell | 3.47777878 |
| 10 | MP0005083_abnormal_biliary_tract | 2.94038846 |
| 11 | MP0003195_calcinosis | 2.93701816 |
| 12 | MP0005332_abnormal_amino_acid | 2.77531354 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.55326925 |
| 14 | MP0005377_hearing/vestibular/ear_phenot | 2.53526431 |
| 15 | MP0003878_abnormal_ear_physiology | 2.53526431 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.32547645 |
| 17 | MP0001986_abnormal_taste_sensitivity | 2.16446486 |
| 18 | MP0000609_abnormal_liver_physiology | 2.14330212 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 2.09867904 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 2.05537288 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.02599033 |
| 22 | MP0003136_yellow_coat_color | 1.92607757 |
| 23 | MP0005551_abnormal_eye_electrophysiolog | 1.89296301 |
| 24 | MP0005319_abnormal_enzyme/_coenzyme | 1.80717704 |
| 25 | MP0003868_abnormal_feces_composition | 1.78341918 |
| 26 | MP0001764_abnormal_homeostasis | 1.71129347 |
| 27 | MP0009697_abnormal_copulation | 1.69045016 |
| 28 | MP0001485_abnormal_pinna_reflex | 1.66415856 |
| 29 | MP0002102_abnormal_ear_morphology | 1.56323637 |
| 30 | MP0000569_abnormal_digit_pigmentation | 1.56132231 |
| 31 | MP0003646_muscle_fatigue | 1.53622468 |
| 32 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.51747030 |
| 33 | MP0004142_abnormal_muscle_tone | 1.42070328 |
| 34 | MP0005451_abnormal_body_composition | 1.37709418 |
| 35 | MP0003011_delayed_dark_adaptation | 1.33777541 |
| 36 | MP0008877_abnormal_DNA_methylation | 1.32786646 |
| 37 | MP0001501_abnormal_sleep_pattern | 1.32487770 |
| 38 | MP0006292_abnormal_olfactory_placode | 1.32274912 |
| 39 | MP0005253_abnormal_eye_physiology | 1.31347711 |
| 40 | MP0009643_abnormal_urine_homeostasis | 1.26151338 |
| 41 | MP0009745_abnormal_behavioral_response | 1.25461141 |
| 42 | MP0001968_abnormal_touch/_nociception | 1.24809049 |
| 43 | MP0006072_abnormal_retinal_apoptosis | 1.23942835 |
| 44 | MP0003186_abnormal_redox_activity | 1.23098330 |
| 45 | MP0004043_abnormal_pH_regulation | 1.22548567 |
| 46 | MP0002736_abnormal_nociception_after | 1.20543435 |
| 47 | MP0002638_abnormal_pupillary_reflex | 1.18113346 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 1.17990548 |
| 49 | MP0003283_abnormal_digestive_organ | 1.16378804 |
| 50 | MP0000598_abnormal_liver_morphology | 1.14128097 |
| 51 | MP0000604_amyloidosis | 1.14113216 |
| 52 | MP0009046_muscle_twitch | 1.13697110 |
| 53 | MP0005647_abnormal_sex_gland | 1.12857867 |
| 54 | MP0009764_decreased_sensitivity_to | 1.10787897 |
| 55 | MP0003705_abnormal_hypodermis_morpholog | 1.07310984 |
| 56 | MP0001486_abnormal_startle_reflex | 1.04660508 |
| 57 | MP0009763_increased_sensitivity_to | 1.03280897 |
| 58 | MP0009785_altered_susceptibility_to | 1.02860414 |
| 59 | MP0002653_abnormal_ependyma_morphology | 1.02288720 |
| 60 | MP0002938_white_spotting | 1.00829257 |
| 61 | MP0004742_abnormal_vestibular_system | 0.99680776 |
| 62 | MP0005174_abnormal_tail_pigmentation | 0.99114382 |
| 63 | MP0002234_abnormal_pharynx_morphology | 0.97016304 |
| 64 | MP0002254_reproductive_system_inflammat | 0.95801139 |
| 65 | MP0008469_abnormal_protein_level | 0.93549205 |
| 66 | MP0005646_abnormal_pituitary_gland | 0.93368290 |
| 67 | MP0004885_abnormal_endolymph | 0.93161574 |
| 68 | MP0002277_abnormal_respiratory_mucosa | 0.92895475 |
| 69 | MP0010368_abnormal_lymphatic_system | 0.92655535 |
| 70 | MP0005645_abnormal_hypothalamus_physiol | 0.91029150 |
| 71 | MP0002272_abnormal_nervous_system | 0.90210340 |
| 72 | MP0000372_irregular_coat_pigmentation | 0.89585255 |
| 73 | * MP0005636_abnormal_mineral_homeostasis | 0.88558120 |
| 74 | * MP0009642_abnormal_blood_homeostasis | 0.87837675 |
| 75 | MP0005671_abnormal_response_to | 0.87714552 |
| 76 | MP0001324_abnormal_eye_pigmentation | 0.87582644 |
| 77 | MP0002064_seizures | 0.86237968 |
| 78 | MP0005670_abnormal_white_adipose | 0.83406158 |
| 79 | MP0001919_abnormal_reproductive_system | 0.83065082 |
| 80 | MP0005084_abnormal_gallbladder_morpholo | 0.81900327 |
| 81 | MP0002282_abnormal_trachea_morphology | 0.81472247 |
| 82 | MP0005386_behavior/neurological_phenoty | 0.80989925 |
| 83 | MP0004924_abnormal_behavior | 0.80989925 |
| 84 | MP0005376_homeostasis/metabolism_phenot | 0.80423712 |
| 85 | MP0005408_hypopigmentation | 0.79410651 |
| 86 | MP0005171_absent_coat_pigmentation | 0.78504773 |
| 87 | MP0006036_abnormal_mitochondrial_physio | 0.78462532 |
| 88 | MP0004147_increased_porphyrin_level | 0.77656366 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.77156550 |
| 90 | MP0002876_abnormal_thyroid_physiology | 0.75474084 |
| 91 | MP0002078_abnormal_glucose_homeostasis | 0.75428427 |
| 92 | MP0003690_abnormal_glial_cell | 0.75281593 |
| 93 | MP0005195_abnormal_posterior_eye | 0.72658289 |
| 94 | MP0003137_abnormal_impulse_conducting | 0.72282019 |
| 95 | MP0002971_abnormal_brown_adipose | 0.71788654 |
| 96 | MP0009053_abnormal_anal_canal | 0.71340745 |
| 97 | MP0003329_amyloid_beta_deposits | 0.71284040 |
| 98 | MP0004215_abnormal_myocardial_fiber | 0.70864950 |
| 99 | MP0005410_abnormal_fertilization | 0.69808440 |
| 100 | MP0004133_heterotaxia | 0.68910549 |
| 101 | MP0002735_abnormal_chemical_nociception | 0.68664978 |
| 102 | MP0005334_abnormal_fat_pad | 0.68434061 |
| 103 | MP0000026_abnormal_inner_ear | 0.68149432 |
| 104 | MP0001963_abnormal_hearing_physiology | 0.67924806 |
| 105 | MP0005220_abnormal_exocrine_pancreas | 0.67037667 |
| 106 | MP0002229_neurodegeneration | 0.66886817 |
| 107 | MP0010386_abnormal_urinary_bladder | 0.66859315 |
| 108 | MP0001529_abnormal_vocalization | 0.65069813 |
| 109 | MP0005389_reproductive_system_phenotype | 0.64897677 |
| 110 | MP0005535_abnormal_body_temperature | 0.64617765 |
| 111 | MP0002148_abnormal_hypersensitivity_rea | 0.64460375 |
| 112 | MP0004130_abnormal_muscle_cell | 0.64406761 |
| 113 | MP0002557_abnormal_social/conspecific_i | 0.63903953 |
| 114 | MP0002572_abnormal_emotion/affect_behav | 0.62427107 |
| 115 | MP0005266_abnormal_metabolism | 0.62005034 |
| 116 | MP0000639_abnormal_adrenal_gland | 0.59815190 |
| 117 | MP0005464_abnormal_platelet_physiology | 0.59192974 |
| 118 | MP0001756_abnormal_urination | 0.57361147 |
| 119 | MP0001661_extended_life_span | 0.56958884 |
| 120 | MP0005448_abnormal_energy_balance | 0.52769868 |
| 121 | MP0008874_decreased_physiological_sensi | 0.50468946 |
| 122 | MP0002822_catalepsy | 0.48197075 |
| 123 | MP0003638_abnormal_response/metabolism_ | 0.47305231 |
| 124 | MP0002136_abnormal_kidney_physiology | 0.46888982 |
| 125 | MP0005395_other_phenotype | 0.46647690 |
| 126 | MP0006035_abnormal_mitochondrial_morpho | 0.46593870 |
| 127 | MP0003724_increased_susceptibility_to | 0.46570644 |
| 128 | MP0008873_increased_physiological_sensi | 0.46360642 |
| 129 | MP0003075_altered_response_to | 0.43376296 |
| 130 | MP0003436_decreased_susceptibility_to | 0.42288370 |
| 131 | MP0002928_abnormal_bile_duct | 0.42018445 |
| 132 | MP0003718_maternal_effect | 0.40772002 |
| 133 | MP0004782_abnormal_surfactant_physiolog | 0.40565258 |
| 134 | MP0003953_abnormal_hormone_level | 0.39996236 |
| 135 | MP0005166_decreased_susceptibility_to | 0.39063809 |
| 136 | MP0008872_abnormal_physiological_respon | 0.38171246 |
| 137 | MP0002837_dystrophic_cardiac_calcinosis | 0.38101050 |
| 138 | MP0000579_abnormal_nail_morphology | 0.37793312 |
| 139 | MP0005248_abnormal_Harderian_gland | 0.35284058 |
| 140 | MP0001881_abnormal_mammary_gland | 0.35110402 |
| 141 | MP0005666_abnormal_adipose_tissue | 0.34575044 |
| 142 | MP0000249_abnormal_blood_vessel | 0.33786458 |
| 143 | MP0009115_abnormal_fat_cell | 0.33427704 |
| 144 | MP0006082_CNS_inflammation | 0.32080433 |
| 145 | MP0002168_other_aberrant_phenotype | 0.31939393 |
| 146 | MP0004883_abnormal_blood_vessel | 0.31667173 |
| 147 | MP0009672_abnormal_birth_weight | 0.31304044 |
| 148 | MP0001243_abnormal_dermal_layer | 0.30706481 |
| 149 | MP0002970_abnormal_white_adipose | 0.29688116 |
| 150 | MP0001853_heart_inflammation | 0.29369869 |
| 151 | MP0000230_abnormal_systemic_arterial | 0.29115326 |
| 152 | MP0001845_abnormal_inflammatory_respons | 0.28785793 |
| 153 | MP0002796_impaired_skin_barrier | 0.27415260 |
| 154 | MP0005164_abnormal_response_to | 0.27155628 |
| 155 | MP0009384_cardiac_valve_regurgitation | 0.27018653 |
| 156 | MP0004381_abnormal_hair_follicle | 0.26544261 |
| 157 | MP0005167_abnormal_blood-brain_barrier | 0.26364949 |
| 158 | MP0002132_abnormal_respiratory_system | 0.24273456 |
| 159 | MP0002135_abnormal_kidney_morphology | 0.23316053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.51857750 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.39669767 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.14031503 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.95321097 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.64176988 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.60626266 |
| 7 | Xanthomatosis (HP:0000991) | 6.27433637 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.75503696 |
| 9 | Complement deficiency (HP:0004431) | 5.25436182 |
| 10 | Joint hemorrhage (HP:0005261) | 4.88100964 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.87259122 |
| 12 | Hyperammonemia (HP:0001987) | 4.59149941 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.56456790 |
| 14 | Epidermoid cyst (HP:0200040) | 4.49371671 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.43908031 |
| 16 | Abnormality of methionine metabolism (HP:0010901) | 4.35220163 |
| 17 | Ketosis (HP:0001946) | 4.27550622 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.26972070 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.26033706 |
| 20 | Hyperglycinemia (HP:0002154) | 4.23507821 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.17508227 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.13374891 |
| 23 | Fat malabsorption (HP:0002630) | 4.08327967 |
| 24 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.05821133 |
| 25 | Hypoglycemic coma (HP:0001325) | 4.01671184 |
| 26 | Abnormality of complement system (HP:0005339) | 3.82971382 |
| 27 | Hyperglycinuria (HP:0003108) | 3.82192465 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.76460190 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.76460190 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.73809745 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.68707389 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.60479320 |
| 33 | Congenital stationary night blindness (HP:0007642) | 3.45645886 |
| 34 | Spontaneous abortion (HP:0005268) | 3.35185035 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.33579135 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.32636423 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.27444041 |
| 38 | Pancreatic cysts (HP:0001737) | 3.19542641 |
| 39 | Steatorrhea (HP:0002570) | 3.14671612 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.14613058 |
| 41 | Ketoacidosis (HP:0001993) | 3.08612404 |
| 42 | True hermaphroditism (HP:0010459) | 3.08198004 |
| 43 | Myocardial infarction (HP:0001658) | 3.00897222 |
| 44 | Delayed CNS myelination (HP:0002188) | 2.99870388 |
| 45 | Fair hair (HP:0002286) | 2.98945110 |
| 46 | Abnormality of serum amino acid levels (HP:0003112) | 2.98921530 |
| 47 | Abnormality of midbrain morphology (HP:0002418) | 2.92586883 |
| 48 | Molar tooth sign on MRI (HP:0002419) | 2.92586883 |
| 49 | Pancreatic fibrosis (HP:0100732) | 2.89976251 |
| 50 | Hepatocellular carcinoma (HP:0001402) | 2.83034028 |
| 51 | Hypochromic microcytic anemia (HP:0004840) | 2.81594751 |
| 52 | Hyperventilation (HP:0002883) | 2.77677013 |
| 53 | Skin nodule (HP:0200036) | 2.76487675 |
| 54 | Abnormality of the renal cortex (HP:0011035) | 2.72780077 |
| 55 | Systemic lupus erythematosus (HP:0002725) | 2.70371599 |
| 56 | Metabolic acidosis (HP:0001942) | 2.69946992 |
| 57 | Hypoglycemic seizures (HP:0002173) | 2.69774601 |
| 58 | Vascular calcification (HP:0004934) | 2.69078351 |
| 59 | Abnormality of purine metabolism (HP:0004352) | 2.69009020 |
| 60 | Mitral stenosis (HP:0001718) | 2.63196476 |
| 61 | Lethargy (HP:0001254) | 2.63071202 |
| 62 | Amyloidosis (HP:0011034) | 2.55578635 |
| 63 | Cerebral edema (HP:0002181) | 2.53057774 |
| 64 | Abolished electroretinogram (ERG) (HP:0000550) | 2.49537096 |
| 65 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.48983188 |
| 66 | Dicarboxylic aciduria (HP:0003215) | 2.48983188 |
| 67 | Spastic diplegia (HP:0001264) | 2.48031526 |
| 68 | Glomerulonephritis (HP:0000099) | 2.46430561 |
| 69 | Nephronophthisis (HP:0000090) | 2.45797653 |
| 70 | Gingival bleeding (HP:0000225) | 2.45206960 |
| 71 | Abnormal gallbladder morphology (HP:0012437) | 2.42313654 |
| 72 | Chronic hepatic failure (HP:0100626) | 2.41390470 |
| 73 | Irritability (HP:0000737) | 2.39744450 |
| 74 | Attenuation of retinal blood vessels (HP:0007843) | 2.39549741 |
| 75 | Late onset (HP:0003584) | 2.39308173 |
| 76 | Cardiovascular calcification (HP:0011915) | 2.38940200 |
| 77 | Neonatal onset (HP:0003623) | 2.37538624 |
| 78 | Bile duct proliferation (HP:0001408) | 2.37537158 |
| 79 | Abnormal biliary tract physiology (HP:0012439) | 2.37537158 |
| 80 | Cholelithiasis (HP:0001081) | 2.36860268 |
| 81 | Type II lissencephaly (HP:0007260) | 2.35175603 |
| 82 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.34766932 |
| 83 | Acanthocytosis (HP:0001927) | 2.34573807 |
| 84 | Decreased central vision (HP:0007663) | 2.33190522 |
| 85 | Gout (HP:0001997) | 2.26912281 |
| 86 | Abnormality of alanine metabolism (HP:0010916) | 2.26324927 |
| 87 | Hyperalaninemia (HP:0003348) | 2.26324927 |
| 88 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.26324927 |
| 89 | Hypothermia (HP:0002045) | 2.25644598 |
| 90 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.23351919 |
| 91 | Generalized hypopigmentation of hair (HP:0011358) | 2.22667687 |
| 92 | Abnormality of the renal medulla (HP:0100957) | 2.19470207 |
| 93 | Cholecystitis (HP:0001082) | 2.19397117 |
| 94 | Abnormal gallbladder physiology (HP:0012438) | 2.19397117 |
| 95 | Menorrhagia (HP:0000132) | 2.18889814 |
| 96 | Abnormal drinking behavior (HP:0030082) | 2.18735103 |
| 97 | Polydipsia (HP:0001959) | 2.18735103 |
| 98 | Thrombophlebitis (HP:0004418) | 2.17423563 |
| 99 | Brushfield spots (HP:0001088) | 2.17407331 |
| 100 | Medial flaring of the eyebrow (HP:0010747) | 2.14769936 |
| 101 | Malnutrition (HP:0004395) | 2.12605904 |
| 102 | Esophageal varix (HP:0002040) | 2.11775886 |
| 103 | Congenital, generalized hypertrichosis (HP:0004540) | 2.11593421 |
| 104 | Pancreatitis (HP:0001733) | 2.09066949 |
| 105 | 3-Methylglutaconic aciduria (HP:0003535) | 2.08658968 |
| 106 | Sensorimotor neuropathy (HP:0007141) | 2.07897381 |
| 107 | Vomiting (HP:0002013) | 2.07094001 |
| 108 | Opisthotonus (HP:0002179) | 2.04903774 |
| 109 | Abnormality of urine glucose concentration (HP:0011016) | 2.04149611 |
| 110 | Glycosuria (HP:0003076) | 2.04149611 |
| 111 | Pendular nystagmus (HP:0012043) | 2.03677832 |
| 112 | Enlarged kidneys (HP:0000105) | 2.01954137 |
| 113 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.01272761 |
| 114 | Inability to walk (HP:0002540) | 1.99112955 |
| 115 | Poikilocytosis (HP:0004447) | 1.98748865 |
| 116 | Hemorrhage of the eye (HP:0011885) | 1.97675531 |
| 117 | Cystic liver disease (HP:0006706) | 1.97271717 |
| 118 | Mitochondrial inheritance (HP:0001427) | 1.95463663 |
| 119 | Acute encephalopathy (HP:0006846) | 1.95400902 |
| 120 | Abnormality of the gallbladder (HP:0005264) | 1.94961756 |
| 121 | Generalized aminoaciduria (HP:0002909) | 1.94437549 |
| 122 | Rickets (HP:0002748) | 1.92775970 |
| 123 | Increased CSF lactate (HP:0002490) | 1.91945348 |
| 124 | Hypophosphatemic rickets (HP:0004912) | 1.91100530 |
| 125 | Hyperglycemia (HP:0003074) | 1.90796791 |
| 126 | Tubular atrophy (HP:0000092) | 1.87875072 |
| 127 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.87457895 |
| 128 | Absent/shortened dynein arms (HP:0200106) | 1.87457895 |
| 129 | Abnormality of proline metabolism (HP:0010907) | 1.87101157 |
| 130 | Hydroxyprolinuria (HP:0003080) | 1.87101157 |
| 131 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.86740599 |
| 132 | Decreased circulating renin level (HP:0003351) | 1.85035514 |
| 133 | Acute necrotizing encephalopathy (HP:0006965) | 1.84865213 |
| 134 | Abnormal cartilage morphology (HP:0002763) | 1.83257102 |
| 135 | Nephritis (HP:0000123) | 1.82995738 |
| 136 | Alkalosis (HP:0001948) | 1.82919919 |
| 137 | Polyuria (HP:0000103) | 1.82060430 |
| 138 | Methylmalonic acidemia (HP:0002912) | 1.81610413 |
| 139 | Keratoconus (HP:0000563) | 1.79212648 |
| 140 | Increased corneal curvature (HP:0100692) | 1.79212648 |
| 141 | Elevated hepatic transaminases (HP:0002910) | 1.76846816 |
| 142 | Mesangial abnormality (HP:0001966) | 1.76149007 |
| 143 | Abnormal urine output (HP:0012590) | 1.75933514 |
| 144 | Renal cortical cysts (HP:0000803) | 1.75377186 |
| 145 | Lipid accumulation in hepatocytes (HP:0006561) | 1.75372243 |
| 146 | Symptomatic seizures (HP:0011145) | 1.75361398 |
| 147 | Reticulocytosis (HP:0001923) | 1.75046893 |
| 148 | Hepatic necrosis (HP:0002605) | 1.74196279 |
| 149 | Status epilepticus (HP:0002133) | 1.74030221 |
| 150 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.73596547 |
| 151 | Optic disc pallor (HP:0000543) | 1.70823620 |
| 152 | Abnormality of vitamin metabolism (HP:0100508) | 1.69966991 |
| 153 | Male pseudohermaphroditism (HP:0000037) | 1.69050133 |
| 154 | Congenital sensorineural hearing impairment (HP:0008527) | 1.66932439 |
| 155 | Methylmalonic aciduria (HP:0012120) | 1.66265149 |
| 156 | Thyroiditis (HP:0100646) | 1.65866579 |
| 157 | Progressive inability to walk (HP:0002505) | 1.63818398 |
| 158 | Progressive cerebellar ataxia (HP:0002073) | 1.63528708 |
| 159 | Arthropathy (HP:0003040) | 1.63454932 |
| 160 | Focal motor seizures (HP:0011153) | 1.63292983 |
| 161 | CNS demyelination (HP:0007305) | 1.62088847 |
| 162 | Hepatocellular necrosis (HP:0001404) | 1.61936621 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.07521795 |
| 2 | FGFR4 | 4.67441920 |
| 3 | SIK1 | 4.67333343 |
| 4 | ERN1 | 4.51364000 |
| 5 | ADRBK2 | 3.72025311 |
| 6 | TAOK3 | 3.35118091 |
| 7 | ERBB4 | 2.90017514 |
| 8 | MAP4K2 | 2.87780962 |
| 9 | INSRR | 2.80322075 |
| 10 | ZAK | 2.79292137 |
| 11 | WNK3 | 2.67270159 |
| 12 | BMPR1B | 2.61905913 |
| 13 | TXK | 2.58127344 |
| 14 | WNK4 | 2.55281874 |
| 15 | ACVR1B | 2.46983297 |
| 16 | DAPK2 | 2.40943498 |
| 17 | MAP2K4 | 2.22513567 |
| 18 | PIK3CG | 2.03587627 |
| 19 | MST1R | 1.96803479 |
| 20 | PKN2 | 1.96128750 |
| 21 | MAPK13 | 1.87075053 |
| 22 | MAPK11 | 1.81052468 |
| 23 | FLT3 | 1.74577822 |
| 24 | TRIB3 | 1.68858572 |
| 25 | TLK1 | 1.67849969 |
| 26 | TYK2 | 1.64706226 |
| 27 | PNCK | 1.60222674 |
| 28 | GRK7 | 1.59659401 |
| 29 | CAMKK2 | 1.57618758 |
| 30 | NUAK1 | 1.55665178 |
| 31 | PTK6 | 1.51791913 |
| 32 | OXSR1 | 1.49290840 |
| 33 | ABL2 | 1.47561207 |
| 34 | LATS1 | 1.39867119 |
| 35 | STK39 | 1.35482757 |
| 36 | FRK | 1.33343707 |
| 37 | JAK2 | 1.25840772 |
| 38 | KDR | 1.25557023 |
| 39 | ADRBK1 | 1.25127848 |
| 40 | NEK9 | 1.23752021 |
| 41 | FGFR2 | 1.21982142 |
| 42 | TBK1 | 1.19063243 |
| 43 | MAP3K4 | 1.15380764 |
| 44 | MAP3K14 | 1.10852512 |
| 45 | TGFBR1 | 1.09339592 |
| 46 | MAP3K7 | 1.09235844 |
| 47 | GRK6 | 1.09216665 |
| 48 | MAPK15 | 1.06844610 |
| 49 | IKBKB | 1.05554561 |
| 50 | CASK | 1.04330737 |
| 51 | PRKAA2 | 1.03716510 |
| 52 | CCNB1 | 1.03326833 |
| 53 | EPHB1 | 1.02969882 |
| 54 | ERBB2 | 1.00893370 |
| 55 | VRK1 | 1.00754993 |
| 56 | PINK1 | 1.00090628 |
| 57 | JAK1 | 0.99135671 |
| 58 | DYRK2 | 0.96389398 |
| 59 | MAP2K3 | 0.94788756 |
| 60 | MAPK4 | 0.93922565 |
| 61 | MUSK | 0.91556343 |
| 62 | EPHA3 | 0.90510197 |
| 63 | PRKCZ | 0.90364274 |
| 64 | BRSK2 | 0.90148915 |
| 65 | MAPKAPK3 | 0.89526405 |
| 66 | MAP3K11 | 0.89115758 |
| 67 | MAPK12 | 0.87311653 |
| 68 | PDK2 | 0.84262971 |
| 69 | CAMK2G | 0.84136216 |
| 70 | PRKCE | 0.82743138 |
| 71 | TSSK6 | 0.80475281 |
| 72 | PRKACG | 0.80113078 |
| 73 | TNIK | 0.78796178 |
| 74 | MET | 0.78578149 |
| 75 | MAP3K10 | 0.78475854 |
| 76 | MAP2K6 | 0.77630656 |
| 77 | MAP3K3 | 0.76598989 |
| 78 | NTRK3 | 0.76156868 |
| 79 | WEE1 | 0.75877162 |
| 80 | DYRK1B | 0.75857564 |
| 81 | CSK | 0.74553400 |
| 82 | NTRK2 | 0.73487049 |
| 83 | TIE1 | 0.73199224 |
| 84 | TEC | 0.71775050 |
| 85 | EPHA4 | 0.71385504 |
| 86 | CDK6 | 0.71100107 |
| 87 | TNK2 | 0.68820971 |
| 88 | PIK3CA | 0.67741634 |
| 89 | MAPKAPK5 | 0.67514340 |
| 90 | SYK | 0.67034561 |
| 91 | RIPK1 | 0.66489351 |
| 92 | CAMK1D | 0.66428270 |
| 93 | CHUK | 0.66397695 |
| 94 | IKBKE | 0.63497542 |
| 95 | STK38L | 0.62116028 |
| 96 | PHKG2 | 0.60699065 |
| 97 | PHKG1 | 0.60699065 |
| 98 | MKNK2 | 0.60592050 |
| 99 | GSK3A | 0.60315151 |
| 100 | PRKAA1 | 0.55799745 |
| 101 | PDPK1 | 0.55107106 |
| 102 | MAP2K1 | 0.54848124 |
| 103 | MAP4K1 | 0.54786998 |
| 104 | PTK2 | 0.54760873 |
| 105 | CSF1R | 0.54271631 |
| 106 | SGK3 | 0.54100985 |
| 107 | NLK | 0.53899681 |
| 108 | MAPK7 | 0.53758288 |
| 109 | IRAK1 | 0.53332240 |
| 110 | CSNK1G1 | 0.51408318 |
| 111 | LYN | 0.49991181 |
| 112 | TGFBR2 | 0.49861819 |
| 113 | TAOK2 | 0.49516640 |
| 114 | PRKG1 | 0.49388048 |
| 115 | PRKCQ | 0.48970539 |
| 116 | IRAK3 | 0.48931617 |
| 117 | FGFR3 | 0.47856548 |
| 118 | MAP3K13 | 0.47086323 |
| 119 | IGF1R | 0.46917941 |
| 120 | MARK1 | 0.46697817 |
| 121 | ITK | 0.46447455 |
| 122 | BLK | 0.46418120 |
| 123 | RPS6KA5 | 0.44788345 |
| 124 | PRKCG | 0.44651348 |
| 125 | PKN1 | 0.44154507 |
| 126 | TRIM28 | 0.40162198 |
| 127 | ICK | 0.40103914 |
| 128 | CAMK2A | 0.39799157 |
| 129 | STK11 | 0.39608587 |
| 130 | CAMK4 | 0.39292667 |
| 131 | CSNK1A1 | 0.39093150 |
| 132 | CSNK1G3 | 0.37613245 |
| 133 | GRK1 | 0.37248023 |
| 134 | CSNK1G2 | 0.36995554 |
| 135 | SGK2 | 0.36584771 |
| 136 | VRK2 | 0.36329666 |
| 137 | MAP2K7 | 0.36033614 |
| 138 | EGFR | 0.35943468 |
| 139 | RET | 0.35433791 |
| 140 | CDK4 | 0.35216334 |
| 141 | MTOR | 0.35069503 |
| 142 | MAP3K5 | 0.34827362 |
| 143 | FER | 0.34765062 |
| 144 | PDK1 | 0.34229675 |
| 145 | LCK | 0.34219237 |
| 146 | ABL1 | 0.33881935 |
| 147 | GRK5 | 0.32376280 |
| 148 | CSNK1D | 0.30451068 |
| 149 | JAK3 | 0.30420450 |
| 150 | PRKCA | 0.29272326 |
| 151 | MAP2K2 | 0.29164882 |
| 152 | CSNK1A1L | 0.28105669 |
| 153 | MAP3K1 | 0.27563779 |
| 154 | MKNK1 | 0.26935359 |
| 155 | PRKACB | 0.25384503 |
| 156 | PAK3 | 0.25052849 |
| 157 | PBK | 0.24777808 |
| 158 | SGK223 | 0.24400337 |
| 159 | SGK494 | 0.24400337 |
| 160 | LATS2 | 0.22844885 |
| 161 | KIT | 0.22462107 |
| 162 | MAPK3 | 0.20993437 |
| 163 | BMX | 0.19776797 |
| 164 | MAP3K6 | 0.19744896 |
| 165 | PRKACA | 0.18682810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.55146426 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.44525948 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.36021093 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.35616985 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.12337127 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.80239595 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.72027115 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.64109281 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.56232411 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.54081181 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.39991393 |
| 12 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.34619180 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.32991853 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25731255 |
| 15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.13598895 |
| 16 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.10426025 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.10213323 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.07773143 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93562858 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.90495518 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.90138952 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87951847 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.85924998 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.80200385 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79567558 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74594156 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.71540864 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69490677 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.66491011 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64919970 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.61408473 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56536252 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51386009 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.48029148 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48022609 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.47912662 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.45841366 |
| 38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34651275 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31971349 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31717077 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.29916166 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28984336 |
| 43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.27645239 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.24672629 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19815446 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19653779 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.19541863 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17301282 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.09285248 |
| 50 | Phototransduction_Homo sapiens_hsa04744 | 1.08609805 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.07670417 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05141833 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99642939 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98655627 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97940704 |
| 56 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.95768441 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95541829 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.91045290 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90821632 |
| 60 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.82880315 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81991980 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81115031 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79374530 |
| 64 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.78764347 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.77382993 |
| 66 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.76598154 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.74665575 |
| 68 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.74030639 |
| 69 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.70063482 |
| 70 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69768649 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63600206 |
| 72 | Asthma_Homo sapiens_hsa05310 | 0.62897143 |
| 73 | Protein export_Homo sapiens_hsa03060 | 0.62123486 |
| 74 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57622327 |
| 75 | Parkinsons disease_Homo sapiens_hsa05012 | 0.55880689 |
| 76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54307957 |
| 77 | Nicotine addiction_Homo sapiens_hsa05033 | 0.53904344 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46840330 |
| 79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46232914 |
| 80 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44804295 |
| 81 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.40414291 |
| 82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.40054404 |
| 83 | Homologous recombination_Homo sapiens_hsa03440 | 0.39331691 |
| 84 | Mineral absorption_Homo sapiens_hsa04978 | 0.39309962 |
| 85 | RNA polymerase_Homo sapiens_hsa03020 | 0.37909265 |
| 86 | Taste transduction_Homo sapiens_hsa04742 | 0.37350970 |
| 87 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.36507803 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.34716889 |
| 89 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.33368239 |
| 90 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.32268945 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.30508797 |
| 92 | Allograft rejection_Homo sapiens_hsa05330 | 0.30204715 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.30173840 |
| 94 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.30162636 |
| 95 | Basal transcription factors_Homo sapiens_hsa03022 | 0.29935072 |
| 96 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.27609119 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27386955 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24020004 |
| 99 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.23968461 |
| 100 | Alzheimers disease_Homo sapiens_hsa05010 | 0.23214568 |
| 101 | Huntingtons disease_Homo sapiens_hsa05016 | 0.21909077 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20866031 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.20697452 |
| 104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20297107 |
| 105 | GABAergic synapse_Homo sapiens_hsa04727 | 0.19954339 |
| 106 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.19034459 |
| 107 | Olfactory transduction_Homo sapiens_hsa04740 | 0.18850680 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18832433 |
| 109 | Morphine addiction_Homo sapiens_hsa05032 | 0.16201598 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13388918 |
| 111 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.12771349 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10297393 |
| 113 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.2538022 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2507052 |
| 115 | Pertussis_Homo sapiens_hsa05133 | -0.2470352 |
| 116 | Amoebiasis_Homo sapiens_hsa05146 | -0.2297627 |
| 117 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2289477 |
| 118 | Bladder cancer_Homo sapiens_hsa05219 | -0.2096180 |
| 119 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1972882 |
| 120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1955178 |
| 121 | Hepatitis C_Homo sapiens_hsa05160 | -0.1835573 |
| 122 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1806183 |
| 123 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1746306 |
| 124 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1727830 |
| 125 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1659719 |
| 126 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1599881 |
| 127 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1555846 |
| 128 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1555392 |
| 129 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1244415 |
| 130 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1080310 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0885066 |
| 132 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0489987 |
| 133 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0208591 |
| 134 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0008944 |

